Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Anti Angiogenesis”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT01354431
What this trial is testing

BMS-936558 (MDX-1106) In Subjects With Advanced/Metastatic Clear-Cell Renal Cell Carcinoma (RCC)

Who this might be right for
Renal Cell Carcinoma
Bristol-Myers Squibb 168
Early research (Phase 1)Study completedNCT00619424
What this trial is testing

A Phase I Study Of Pazopanib With Either Erlotinib Or Pemetrexed In Patients With Advanced Solid Tumors

Who this might be right for
Lung Cancer, Non-Small Cell
GlaxoSmithKline 58
Early research (Phase 1)Study completedNCT00874588
What this trial is testing

Peptide Vaccine Targeting to Cancer Specific Antigen Combined With Anti-angiogenic Peptide Antigen in Treating Patients With Non-small Cell Lung Cancer

Who this might be right for
Non Small Cell Lung Cancer
Fukushima Medical University 6
Testing effectiveness (Phase 2)Study completedNCT00577122
What this trial is testing

Medroxyprogesterone +/- Cyclophosphamide & Methotrexate in Hormone Receptor-Negative Recurrent/Metastatic Breast Cancer

Who this might be right for
Estrogen Receptor-negative Breast CancerProgesterone Receptor-negative Breast CancerRecurrent Breast Cancer+1 more
Indiana University 30
Not applicableWithdrawnNCT01977586
What this trial is testing

Functional Imaging in the Assessment of mRCC Response to Sunitinib

Who this might be right for
Metastatic Renal Cell Carcinoma
Imperial College Healthcare NHS Trust
Testing effectiveness (Phase 2)Study completedNCT00083707
What this trial is testing

Anti-Angiogenesis Therapy Using Thalidomide in Patients With Waldenstrom's Macroglobulinemia

Who this might be right for
Waldenstrom Macroglobulinemia
University of Arkansas 40
Early research (Phase 1)Ended earlyNCT00704821
What this trial is testing

PTC299 for Treatment of Advanced Cancer

Who this might be right for
Advanced Cancer
PTC Therapeutics 76
Not applicableStudy completedNCT00489697
What this trial is testing

Evaluation of Contrast-enhanced Ultrasound Imaging for the Early Estimate of Bevacizumab Effect on Colorectal Cancer Liver Metastases

Who this might be right for
Metastatic Colorectal Cancer
University Hospital, Tours 200
Large-scale testing (Phase 3)UnknownNCT05313282
What this trial is testing

A Trial of Hepatic Arterial Infusion Combined With Apatinib and Camrelizumab Versus Apatinib and Camrelizumab for C-staged Hepatocellular Carcinoma in BCLC Classification

Who this might be right for
C-staged Hepatocellular Carcinoma in BCLC Classification
Sun Yat-sen University 140
Testing effectiveness (Phase 2)Study completedNCT01752049
What this trial is testing

Topical Anti-angiogenic Therapy for Telangiectasia in HHT: Proof of Concept

Who this might be right for
Hereditary Hemorrhagic Telangiectasia
Unity Health Toronto 5
Early research (Phase 1)UnknownNCT06075849
What this trial is testing

Phase I Study to Evaluate Safety and Anti-tumor Activity of PB101, an Anti-angiogenic Immunomodulating Agent

Who this might be right for
Solid Tumor, AdultSolid TumorGastric Cancer+3 more
Panolos Bioscience 30
Early research (Phase 1)Study completedNCT00403221
What this trial is testing

Phase I - Pre-Radical Prostatectomy RTVP-1 Gene Therapy for Prostate Cancer

Who this might be right for
Prostatic Neoplasms
Baylor College of Medicine 19
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07818304
What this trial is testing

SRT Combined With Envafolimab and Endostar in the First-line Treatment of Advanced NSCLC

Who this might be right for
Non Small Cell Lung CancerLung Neoplasms
The First People's Hospital of Lianyungang 61
Testing effectiveness (Phase 2)UnknownNCT04670913
What this trial is testing

Camrelizumab Plus Apatinib for Advanced Non-Squamous NSCLC Previously Treated With First-Line Immunotherapy

Who this might be right for
Advanced Non Squamous NSCLC
Junling Li 30
Testing effectiveness (Phase 2)Study completedNCT00995007
What this trial is testing

Phase II Trial of Vandetanib (ZD6474) in Combination With Carboplatin Versus Carboplatin Alone Followed by Vandetanib Alone in Adults With Recurrent High-Grade Gliomas

Who this might be right for
Glioblastoma MultiformeGliosarcomaAnaplastic Astrocytoma+2 more
National Cancer Institute (NCI) 112
Early research (Phase 1)UnknownNCT03050411
What this trial is testing

Apatinib Combine With EGFR-TKI for Advanced EGFR-TKI-resistant Non-Small Cell Lung Cancer

Who this might be right for
Nonsmall Cell Lung Cancer
Peking University Third Hospital 30
Large-scale testing (Phase 3)Study completedNCT03042611
What this trial is testing

Evaluate Rivoceranib Plus Best Supportive Care Compared to Placebo Plus Best Supportive Care in Participants With Gastric Cancer

Who this might be right for
Gastric CancerGastric Adenocarcinoma
Elevar Therapeutics 460
Testing effectiveness (Phase 2)UnknownNCT05460195
What this trial is testing

Sintilimab Combined With Anlotinib for Perioperative Non-small Cell Lung Cancer Based on MRD Evaluation

Who this might be right for
Non-small Cell Lung CancerMinimal Residual DiseaseImmunotherapy+1 more
Shanghai Chest Hospital 42
Testing effectiveness (Phase 2)Ended earlyNCT03387514
What this trial is testing

Functional Microscale Organotypic Assays to Predict Patient Response to Anti-Angiogenesis Therapies

Who this might be right for
Renal Cell Carcinoma
University of Wisconsin, Madison 5
Testing effectiveness (Phase 2)UnknownNCT03742193
What this trial is testing

Pulmonary Resectable Metastases of Osteosarcoma With Anti-angiogenics and CHemotherapy

Who this might be right for
OsteosarcomaPulmonary MetastasesApatinib
Ruijin Hospital 43
Next Page